These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. Effectiveness of lamivudine and interferon-alpha combination therapy versus interferon-alpha monotherapy for the treatment of HBeAg-negative chronic hepatitis B patients: a randomized clinical trial. Karabay O, Tamer A, Tahtaci M, Vardi S, Celebi H. J Microbiol Immunol Infect; 2005 Aug; 38(4):262-6. PubMed ID: 16118673 [Abstract] [Full Text] [Related]
11. [Correlation of HBV DNA level and viral breakthrough during lamivudine therapy for chronic hepatitis B]. Park HS, Lee DH, Heo J, Kim GH, Kang DH, Song GA, Cho M. Korean J Hepatol; 2006 Jun; 12(2):173-83. PubMed ID: 16804342 [Abstract] [Full Text] [Related]
17. The predictive value of liver fibrosis in determining the effectiveness of interferon and lamivudine therapies for chronic hepatitis B. Shindo M, Hamada K, Nishioji K, Muramatsu A, Oda Y, Okuno T. J Gastroenterol; 2004 Jun; 39(3):260-7. PubMed ID: 15065004 [Abstract] [Full Text] [Related]
18. Management of hepatitis B after renal transplantation: an update. Fabrizi F, Lunghi G, Poordad FF, Martin P. J Nephrol; 2002 Jun; 15(2):113-22. PubMed ID: 12018626 [Abstract] [Full Text] [Related]